TP53 and breast carcinoma: Among gene panel screening of 982 female BC (breast cancer) patients [average age; 48.2 years], two were found to harbor a TP53 mutation, indicating a frequency of germline TP53 mutations in 0.2% of women with BC fulfilling the criteria for genetic screening.